Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting sphingosine kinase 1/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth
Yuhang Xue, Kanqiu Jiang, Li Ou, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Recent progress in targeted therapy for non-small cell lung cancer
Yanxia Xiao, Pu Liu, Jie Wei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 44
A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo
Yuanyuan Mi, Yu Ji, Lifeng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Bioactive sphingolipids as emerging targets for signal transduction in cancer development
Wentao Jia, Jiaying Yuan, Jinbo Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189176-189176
Closed Access | Times Cited: 5
Theoretical Framework and Emerging Challenges of Lipid Metabolism in Cancer
Qiuying Gu, Yuan Wang, Ping Yi, et al.
Seminars in Cancer Biology (2024)
Open Access | Times Cited: 5
Single‐cell RNA sequencing reveals aberrant sphingolipid metabolism in non‐small cell lung cancer impacts tumor‐associated macrophages and stimulates angiogenesis via macrophage inhibitory factor signaling
Luyan Shen, Jianwen Liu, Fengling Hu, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 14, pp. 1164-1175
Open Access | Times Cited: 4
The expression and functional role of proline-rich 15 in non-small cell lung cancer
Yong Ji, Han Zhang, Fuxing Gong, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Sphingosine kinase 2 in cancer: A review of its expression, function, and inhibitor development
Yanqun Luo, Haiping Xue, Ying Gao, et al.
International Journal of Biological Macromolecules (2025), pp. 141392-141392
Closed Access
Study on the synthesis, characterization, and antitumor mechanism investigation of QZQ-01115 via targeting sphingosine kinase 2
C X Liu, Yaxin Guo, Yutong Dong, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167829-167829
Closed Access
Loss of SPHK1 fuels inflammation to drive KRAS-mutated lung adenocarcinoma
Andreea Corina Luca, Margarita Kurnaeva, Daniel John, et al.
Cancer Letters (2025), pp. 217733-217733
Closed Access
NADH:ubiquinone oxidoreductase core subunit S8 expression and functional significance in non-small cell lung cancer
Weihua Xu, Hongpeng Fang, Xianbao Cao, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Targeting SphK1/2 by SKI-178 inhibits prostate cancer cell growth
Lü Jin, Jin Zhu, Linya Yao, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 10
MicroRNAs Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study
Davida Mirra, Renata Esposito, Giuseppe Spaziano, et al.
(2024)
Open Access | Times Cited: 2
MicroRNA Monitoring in Human Alveolar Macrophages from Patients with Smoking-Related Lung Diseases: A Preliminary Study
Davida Mirra, Renata Esposito, Giuseppe Spaziano, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1050-1050
Open Access | Times Cited: 2
Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer
Saïda Mebarek, Najwa Skafi, Leyre Brizuela
Cancers (2023) Vol. 15, Iss. 10, pp. 2732-2732
Open Access | Times Cited: 6
Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC
Jin‐Zhi Zhang, Jia Liu, Yixin Xu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 16, pp. 6163-6175
Open Access | Times Cited: 9
Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2
Xiaolan Wang, Caixia Liu, Jian Wang, et al.
Journal of Chemotherapy (2023) Vol. 36, Iss. 5, pp. 411-421
Closed Access | Times Cited: 4
Developing new ceramide analogs against non-small cell lung cancer (NSCLC)
Lu Dai
American Journal of Cancer Research (2024) Vol. 14, Iss. 1, pp. 86-96
Open Access | Times Cited: 1
Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells
Xiaoxia Jin, Shuyun Yang, Xiaoyun Lu, et al.
Breast Cancer Research (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 1
miR-19a mediates the mechanism by which SPHK2 regulates hypopharyngeal squamous cell carcinoma progression through the PI3K/AKT axis.
Ji Song, Yanshi Li, Tao Lu, et al.
PubMed (2023) Vol. 13, Iss. 6, pp. 2342-2359
Closed Access | Times Cited: 3
The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agents
Gabriel da Silva, Thaís Moré Milan, Andréia Machado Leopoldino
Gene (2023) Vol. 897, pp. 148063-148063
Closed Access | Times Cited: 2
Increased expression of REG3A promotes tumorigenic behavior in triple negative breast cancer cells
Xiaoxia Jin, Shuyun Yang, Xiaoyun Lu, et al.
Research Square (Research Square) (2024)
Open Access
An inducible sphingosine kinase 1 in hepatic stellate cells potentiates liver fibrosis
Jin Sol Baek, Ji Hyun Lee, Ji Hye Kim, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116520-116520
Closed Access
A Cyclometalated Iridium(III) Complex Exerts High Anticancer Efficacy via Fatty Acid Beta-Oxidation Inhibition and Sphingolipid Metabolism Reprogramming
Cuiyan Lin, Huiling Wang, Keyu Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 14912-14926
Closed Access
Targeting POLRMT by IMT1 inhibits colorectal cancer cell growth
Hao Wang, Yuxin Liu, Xingsheng Lu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 9
Open Access
Identification of G protein subunit alpha i3 as a promising oncotarget of LUAD
Gaomeng Luo, Wenxuan Hu, Jian Yang, et al.
Cellular Signalling (2024) Vol. 127, pp. 111582-111582
Closed Access
Page 1 - Next Page

Scroll to top